Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Persaud

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Raltegravir pharmacokinetics in neonates following maternal dosingDiana F Clarke, Edward P Acosta, Matthew L Rizk, et al.
JAMA|February 17, 2005
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAARTRichard E Nettles, Tara L Kieffer, Patty Kwon, et al.
Biomedicines|March 29, 2023
How CD4<sup>+</sup> T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation AssaysGiuseppe Rubens Pascucci, Elena Morrocchi, Chiara Pighi, et al.
Frontiers in Immunology|February 7, 2018
B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus VaccineAdriana Weinberg, Jane Lindsey, Ronald Bosch, et al.
Plos One|January 3, 2009
Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infantsAnitha Moorthy, Amita Gupta, Ramesh Bhosale, et al.
The Journal of Infectious Diseases|February 1, 2024
Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 2019Katerina Roznik, Temesgen E Andargie, T Scott Johnston, et al.
Journal of Virology|March 30, 2005
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patientsDaphne Monie, Rachel P Simmons, Richard E Nettles, et al.
The Journal of Infectious Diseases|August 16, 2021
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 SheddingNadine Peart Akindele, Theodore Kouo, Andrew H Karaba, et al.
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Raltegravir pharmacokinetics in neonates following maternal dosingDiana F Clarke, Edward P Acosta, Matthew L Rizk, et al.
JAMA|February 17, 2005
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAARTRichard E Nettles, Tara L Kieffer, Patty Kwon, et al.
Biomedicines|March 29, 2023
How CD4<sup>+</sup> T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation AssaysGiuseppe Rubens Pascucci, Elena Morrocchi, Chiara Pighi, et al.
Frontiers in Immunology|February 7, 2018
B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus VaccineAdriana Weinberg, Jane Lindsey, Ronald Bosch, et al.
Plos One|January 3, 2009
Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infantsAnitha Moorthy, Amita Gupta, Ramesh Bhosale, et al.
The Journal of Infectious Diseases|February 1, 2024
Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 2019Katerina Roznik, Temesgen E Andargie, T Scott Johnston, et al.
Journal of Virology|March 30, 2005
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patientsDaphne Monie, Rachel P Simmons, Richard E Nettles, et al.
The Journal of Infectious Diseases|August 16, 2021
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 SheddingNadine Peart Akindele, Theodore Kouo, Andrew H Karaba, et al.
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Pageof 9